Preview

Кардиология

Расширенный поиск

Механизмы плохой переносимости физической нагрузки у больных сердечной недостаточностью с сохраненной фракцией выброса. Часть I: Роль нарушений со стороны левых камер сердца

https://doi.org/10.18087/cardio.n394

Полный текст:

Аннотация

При нагрузке увеличение доставки кислорода к работающим мышцам достигается за счет четко скоординированного взаимодействия многих органов и систем: сердца, легких, сосудов, скелетных мышц и автономной нервной системы. При сердечной недостаточности с сохраненной ФВ нарушены все механизмы, участвующие в нормальной переносимости нагрузки. В первой части настоящего обзора рассматриваются нарушения со стороны левых камер сердца – диастолическая дисфункция ЛЖ, ослабление сократительного и хроноропного резервов, дисфункция левого предсердия; также представлены возможные способы их медикаментозной коррекции.

Об авторах

А. Г. Овчинников
ФГБУ «НМИЦ кардиологии» Минздрава России
Россия
121552, Москва, ул. 3‑я Черепковская, д. 15а


А. В. Потехина
ФГБУ «НМИЦ кардиологии» Минздрава России
Россия
121552, Москва, ул. 3‑я Черепковская, д. 15а


Н. М. Ибрагимова
ФГБУ «НМИЦ кардиологии» Минздрава России
Россия
121552, Москва, ул. 3‑я Черепковская, д. 15а


Е. А. Барабанова
ФГБОУ ВО «Первый МГМУ имени И.М. Сеченова» МЗ РФ (Сеченовский Университет)
Россия
119991, Москва, ул. Трубецкая, д. 8, стр. 2


Е. Н. Ющук
ФГБОУ ВО «МГМСУ им.А.И. Евдокимова» МЗ РФ
Россия
127473, Москва, ул. Делегатская, д. 20, стр. 1


Ф. Т. Агеев
ФГБУ «НМИЦ кардиологии» Минздрава России
Россия
121552, Москва, ул. 3‑я Черепковская, д. 15а


Список литературы

1. Bursi F, Weston SA, Redfeld MM, Jacobsen SJ, Pakhomov S, Nkomo VT et al. Systolic and Diastolic Heart Failure in the Community. JAMA. 2006;296(18):2209–16. DOI: 10.1001/jama.296.18.2209

2. Borlaug BA. The pathophysiology of heart failure with preserved ejection fraction. Nature Reviews Cardiology. 2014;11(9):507–15. DOI: 10.1038/nrcardio.2014.83

3. Straton JR, Levy WC, Cerqueira MD, Schwartz RS, Abrass IB. Cardiovascular responses to exercise. Effects of aging and exercise training in healthy men. Circulation. 1994;89(4):1648–55. PMID: 8149532

4. Popović ZB, Prasad A, Garcia MJ, Arbab-Zadeh A, Borowski A, Dijk E et al. Relationship among diastolic intraventricular pressure gradients, relaxation, and preload: impact of age and ftness. American Journal of Physiology-Heart and Circulatory Physiology. 2006;290(4):H1454–9. DOI: 10.1152/ajpheart.00902.2005

5. Carrick-Ranson G, Hastings JL, Bhella PS, Shibata S, Fujimoto N, Palmer MD et al. Effect of healthy aging on lef ventricular relaxation and diastolic suction. American Journal of Physiology-Heart and Circulatory Physiology. 2012;303(3):H315–22. DOI: 10.1152/ajpheart.00142.2012

6. Borlaug BA, Redfeld MM, Melenovsky V, Kane GC, Karon BL, Jacobsen SJ et al. Longitudinal Changes in Lef Ventricular Stiffness: A Community-Based Study. Circulation: Heart Failure. 2013;6(5):944–52. DOI: 10.1161/CIRCHEARTFAILURE.113.000383

7. Wohlfahrt P, Redfeld MM, Lopez-Jimenez F, Melenovsky V, Kane GC, Rodeheffer RJ et al. Impact of General and Central Adiposity on Ventricular-Arterial Aging in Women and Men. JACC: Heart Failure. 2014;2(5):489–99. DOI: 10.1016/j.jchf.2014.03.014

8. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension (Dallas, Tex.: 1979). 1996;27(4):849–53. PMID: 8613259

9. Rector TS, Carson PE, Anand IS, McMurray JJ, Zile MR, McKelvie RS et al. Assessment of Long-Term Effects of Irbesartan on Heart Failure with Preserved Ejection Fraction as Measured by the Minnesota Living With Heart Failure Questionnaire in the Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial. Circulation: Heart Failure. 2012;5(2):217–25. DOI: 10.1161/CIRCHEARTFAILURE.111.964221

10. Zile MR, Kjellstrom B, Bennet T, Cho Y, Baicu CF, Aaron MF et al. Effects of Exercise on Lef Ventricular Systolic and Diastolic Properties in Patients With Heart Failure and a Preserved Ejection Fraction Versus Heart Failure and a Reduced Ejection Fraction. Circulation: Heart Failure. 2013;6(3):508–16. DOI: 10.1161/CIRCHEARTFAILURE.112.000216

11. Higginbotham MB, Morris KG, Williams RS, McHale PA, Coleman RE, Cobb FR. Regulation of stroke volume during submaximal and maximal upright exercise in normal man. Circulation Research. 1986;58(2):281–91. PMID: 3948345

12. Beck KC, Randolph LN, Bailey KR, Wood CM, Snyder EM, Johnson BD. Relationship between cardiac output and oxygen consumption during upright cycle exercise in healthy humans. Journal of Applied Physiology. 2006;101(5):1474–80. DOI: 10.1152/japplphysiol.00224.2006

13. Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. European Heart Journal. 2011;32(6):670–9. DOI: 10.1093/eurheartj/ehq426

14. Rowell LB. Human cardiovascular control. – New York: Oxford University Press; 500 p. ISBN 978-0-19-507362-1

15. Chantler PD, Lakata EG, Najjar SS. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. Journal of Applied Physiology. 2008;105(4):1342–51. DOI: 10.1152/japplphysiol.90600.2008

16. Brubaker PH, Joo K-C, Stewart KP, Fray B, Moore B, Kitzman DW. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. Journal of Cardiopulmonary Rehabilitation. 2006;26(2):86–9. PMID: 16569976

17. Poliner LR, Dehmer GJ, Lewis SE, Parkey RW, Blomqvist CG, Willerson JT. Lef ventricular performance in normal subjects: a comparison of the responses to exercise in the upright and supine positions. Circulation. 1980;62(3):528–34. PMID: 7398013

18. Nonogi H, Hess OM, Riter M, Krayenbuehl HP. Diastolic properties of the normal lef ventricle during supine exercise. British Heart Journal. 1988;60(1):30–8. DOI: 10.1136/hrt.60.1.30

19. Cheng CP, Noda T, Nozawa T, Litle WC. Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circulation Research. 1993;72(4):795–806. PMID: 8095187

20. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expres- sion in cardiac hypertrophy and heart failure. Circulation Research. 1994;74(4):555–64. PMID: 8137493

21. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC et al. Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction. Circulation. 2006;114(20):2138–47. DOI: 10.1161/CIRCULATIO-NAHA.106.632745

22. Borbély A, Falcao-Pires I, van Heerebeek L, Hamdani N, Édes I, Gavina C et al. Hypophosphorylation of the Stiff N2B Titin Isoform Raises Cardiomyocyte Resting Tension in Failing Human Myocardium. Circulation Research. 2009;104(6):780–6. DOI: 10.1161/CIRCRESAHA.108.193326

23. Leite-Moreira AM, Almeida-Coelho J, Neves JS, Pires AL, Ferreira-Martins J, Castro-Ferreira R et al. Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load. Cardiovascular Research. 2018;114(5):656–67. DOI: 10.1093/cvr/cvy026

24. Hidalgo C, Granzier H. Tuning the molecular giant titin through phosphorylation: Role in health and disease. Trends in Cardiovascular Medicine. 2013;23(5):165–71. DOI: 10.1016/j.tcm.2012.10.005

25. Paulus WJ. Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. Journal of the American College of Cardiology. 2010;56(11):864–6. DOI: 10.1016/j.jacc.2010.04.041

26. Borlaug BA, Jaber WA, Ommen SR, Lam CSP, Redfeld MM, Nishimura R. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart. 2011;97(12):964–9. DOI: 10.1136/hrt.2010.212787

27. Hay I, Rich J, Ferber P, Burkhoff D, Maurer MS. Role of impaired myocardial relaxation in the production of elevated lef ventricular flling pressure. American Journal of Physiology-Heart and Circulatory Physiology. 2005;288(3):H1203–8. DOI: 10.1152/ajpheart.00681.2004

28. Tan YT, Wenzelburger F, Lee E, Heatlie G, Leyva F, Patel K et al. The Pathophysiology of Heart Failure With Normal Ejection Fraction. Journal of the American College of Cardiology. 2009;54(1):36–46. DOI: 10.1016/j.jacc.2009.03.037

29. Van Heerebeek L, Hamdani N, Falcão-Pires I, Leite-Moreira AF, Begieneman MPV, Bronzwaer JGF et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation. 2012;126(7):830–9. DOI: 10.1161/CIRCULATIONAHA.111.076075

30. Haykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of Exercise Intolerance in Elderly Heart Failure Patients With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2011;58(3):265–74. DOI: 10.1016/j.jacc.2011.02.055

31. Shibata S, Hastings JL, Prasad A, Fu Q, Bhella PS, Pacini E et al. Congestive heart failure with preserved ejection fraction is associated with severely impaired dynamic Starling mechanism. Journal of Applied Physiology. 2011;110(4):964–71. DOI: 10.1152/japplphysiol.00826.2010

32. Abudiab MM, Redfeld MM, Melenovsky V, Olson TP, Kass DA, Johnson BD et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. European Journal of Heart Failure. 2013;15(7):776–85. DOI: 10.1093/eurjhf/hf026

33. Borlaug BA, Nishimura R, Sorajja P, Lam CSP, Redfeld MM. Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction. Circulation: Heart Failure. 2010;3(5):588–95. DOI: 10.1161/CIRCHEARTFAILURE.109.930701

34. Ovchinnikov A.G., Azizova A.G., Masenko V.P., Shatalina L.S., Ageev F.T. The effect of loop diuretics on the clinical course, the flling pressure of the lef ventricle in patients with compensated NSFW and high flling pressure of the LV. Russian Heart Failure Journal. 2012;13 (6):320–33. [Russian: Овчинников А.Г., Азизова А.Г., Масенко В.П., Шаталина Л.С., Агеев Ф.Т. Влияние петлевых диуретиков на клиническое течение, давление наполнения левого желудочка у больных с компенсированной СНСФВ и высоким давлением наполнения ЛЖ. Журнал Сердечная Недостаточность. 2012;13(6):320-33]

35. Hasenfuß G, Hayward C, Burkhoff D, Silvestry FE, McKenzie S, Gustafsson F et al. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. The Lancet. 2016;387(10025):1298–304. DOI: 10.1016/S0140-6736(16)00704-2

36. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Journal of the American College of Cardiology. 2013;62(4):263–71. DOI: 10.1016/j.jacc.2013.02.092

37. Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O et al. Sildenafl and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility In Vivo. Circulation. 2011;124(25):2882–91. DOI: 10.1161/CIRCULATIONAHA.111.048520

38. Ovchinnikov AG, Potekhina AV, Gavryushina SV, Ageev FT. P2138. Sildenafl improves functional capacity and exercise hemodynamics in patients with heart failure with preserved lef ventricular ejection fraction and predominantly combined pre- and post-capillary pulmonary hypertension. European Journal of Heart Failure. 2018;20(Suppl 1):567. DOI: 10.1002/ejhf.1197

39. Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL et al. Cardiac Natriuretic Peptides, Obesity, and Insulin Resistance: Evidence from Two Community-Based Studies. The Journal of Clinical Endocrinology & Metabolism. 2011;96(10):3242–9. DOI: 10.1210/jc.2011-1182

40. Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E et al. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial. The Lancet. 2012;380(9851):1387–95. DOI: 10.1016/S0140-6736(12)61227-6

41. Svirida O.N., Ovchinnikov A.G., Ageev F.T. Influence of candesartan and its combination with spironolactone on lef ventricular diastolic function and level of collagen balance’s biochemical markers in patients with chronic heart failure and preserved lef ventricular systolic function. Russian Heart Failure Journal. 2010;11(5):263–75. [Russian: Свирида О.Н., Овчинников А.Г., Агеев Ф.Т. Влияние кандесартана и его комбинации со спиронолактоном на диастолическую функцию левого желудочка и содержание биохимических маркеров баланса коллагена у пациентов с хронической сердечной недостаточностью и сохраненной систолической функцией левого желудочка. Журнал Сердечная Недостаточность. 2010;11(5):263-75]

42. Kosmala W, Rojek A, Przewlocka-Kosmala M, Wright L, Mysiak A, Marwick TH. Effect of Aldosterone Antagonism on Exercise Tolerance in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2016;68(17):1823–34. DOI: 10.1016/j.jacc.2016.07.763

43. Kass DA, Shapiro EP, Kawaguchi M, Caprioti AR, Scuteri A, deGroof RC et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation. 2001;104(13):1464–70. PMID: 11571237

44. Phan T, Abozguia K, Nallur Shivu G, Ahmed I, Leyva F, Patel K et al. Increased Atrial Contribution to Lef Ventricular Filling Compensates for Impaired Early Filling During Exercise in Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure. 2009;15(10):890–7. DOI: 10.1016/j.cardfail.2009.06.440

45. Tan YT, Wenzelburger F, Lee E, Nightingale P, Heatlie G, Leyva F et al. Reduced lef atrial function on exercise in patients with heart failure and normal ejection fraction. Heart. 2010;96(13):1017–23. DOI: 10.1136/hrt.2009.189118

46. Azizova A.G., Ovchinnikov A.G., Ageev F.T. Comparative study of Torasemide vs. Furosemide effects on clinical status and diastolic function of the lef ventricle in patients with compensated heart failure and high ventricular flling pressure. Russian Heart Failure Journal. 2011;12 (6):326–32. [Russian: Азизова А.Г., Овчинников А.Г., Агеев Ф.Т. Сравнительное влияние торасемида и фуросемида на клинический статус и диастолическую функцию левого желудочка у больных с компенсированной сердечной недостаточностью и высоким давлением наполнения левого желудочка. Журнал Сердечная Недостаточность. 2011;12(6):326-32]

47. Freed BH, Daruwalla V, Cheng JY, Aguilar FG, Beussink L, Choi A et al. Prognostic Utility and Clinical Signifcance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Lef Atrial Strain. Circulation: Cardiovascular Imaging. 2016;9(3):e003754. DOI: 10.1161/CIRCIMAGING.115.003754

48. Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Clagget B, Pieske B et al. Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2014;63(5):447–56. DOI: 10.1016/j.jacc.2013.09.052

49. Shah AM, Clagget B, Sweitzer NK, Shah SJ, Anand IS, Liu L et al. Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circulation. 2015;132(5):402–14. DOI: 10.1161/CIRCULATIONAHA.115.015884

50. Phan T, Abozguia K, Nallur Shivu G, Mahadevan G, Ahmed I, Williams L et al. Heart Failure With Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Lef Ventricle on Exercise and Associated With Myocardial Energy Defciency. Journal of the American College of Cardiology. 2009;54(5):402–9. DOI: 10.1016/j.jacc.2009.05.012

51. Borlaug BA, Olson TP, Lam CSP, Flood KS, Lerman A, Johnson BD et al. Global Cardiovascular Reserve Dysfunction in Heart Failure with Preserved Ejection Fraction. Journal of the American College of Cardiology. 2010;56(11):845–54. DOI: 10.1016/j.jacc.2010.03.077

52. Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. Journal of the American College of Cardiology. 2001;38(3):796–802. PMID: 11527636

53. Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfeld MM. Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction. Circulation. 2015;131(6):550–9. DOI: 10.1161/CIRCULATIO-NAHA.114.009625

54. Liu CP, Ting CT, Lawrence W, Maughan WL, Chang MS, Kass DA. Diminished contractile response to increased heart rate in intact human lef ventricular hypertrophy. Systolic versus diastolic determinants. Circulation. 1993;88(4 Pt 1):1893–906. PMID: 8403335

55. Ohara T, Niebel CL, Stewart KC, Charonko JJ, Pu M, Vlachos PP et al. Loss of Adrenergic Augmentation of Diastolic Intra-LV Pressure Difference in Patients With Diastolic Dysfunction. JACC: Cardiovascular Imaging. 2012;5(9):861–70. DOI: 10.1016/j.jcmg.2012.05.013

56. Smith CS, Botomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium. Circulation. 2006;114(11):1151–8. DOI: 10.1161/CIRCULATIONAHA.106.613646

57. Phan T, Shivu GN, Abozguia K, Davies C, Nassimizadeh M, Jimenez D et al. Impaired Heart Rate Recovery and Chronotropic Incompetence in Patients With Heart Failure With Preserved Ejection Fraction. Circulation: Heart Failure. 2010;3(1):29–34. DOI: 10.1161/CIRCHEARTFAILURE.109.877720

58. Huang P-H. Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test. Heart. 2006;92(5):609–14. DOI: 10.1136/hrt.2005.064147

59. Pandey A, Khera R, Park B, Haykowsky M, Borlaug BA, Lewis GD et al. Relative Impairments in Hemodynamic Exercise Reserve Parameters in Heart Failure With Preserved Ejection Fraction. JACC: Heart Failure. 2018;6(2):117–26. DOI: 10.1016/j.jchf.2017.10.014

60. Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH. Effect of If-Channel Inhibition on Hemodynamic Status and Exercise Tolerance in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2013;62(15):1330–8. DOI: 10.1016/j.jacc.2013.06.043

61. Pal N, Sivaswamy N, Mahmod M, Yavari A, Rudd A, Singh S et al. Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction. Circulation. 2015;132(18):1719–25. DOI: 10.1161/CIRCULATIONAHA.115.017119

62. Zakeri R, Chamberlain AM, Roger VL, Redfeld MM. Temporal Relationship and Prognostic Signifcance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction: A Community-Based Study. Circulation. 2013;128(10):1085–93. DOI: 10.1161/CIRCULATIONAHA.113.001475

63. Melenovsky V, Hwang S-J, Lin G, Redfeld MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. European Heart Journal. 2014;35(48):3452–62. DOI: 10.1093/eurheartj/ehu193

64. Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA et al. Atrial fbrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484–92. DOI: 10.1161/CIRCULATIONAHA.115.018614

65. Elliot AD, Mahajan R, Pathak RK, Lau DH, Sanders P. Exercise Training and Atrial Fibrillation: Further Evidence for the Importance of Lifestyle Change. Circulation. 2016;133(5):457–9. DOI: 10.1161/CIRCULATIONAHA.115.020800

66. Machino-Ohtsuka T, Seo Y, Ishizu T, Sugano A, Atsumi A, Yamamoto M et al. Efcacy, Safety, and Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology. 2013;62(20):1857–65. DOI: 10.1016/j.jacc.2013.07.020

67. Glezeva N, Baugh JA. Role of inflammation in the pathogenesis of heart failure with preserved ejection fraction and its potential as a therapeutic target. Heart Failure Reviews. 2014;19(5):681–94. DOI: 10.1007/s10741-013-9405-8

68. Van Tassell BW, Arena R, Biondi-Zoccai G, McNair Canada J, Oddi C, Abouzaki NA et al. Effects of Interleukin-1 Blockade With Anakinra on Aerobic Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction (from the D-HART Pilot Study). The American Journal of Cardiology. 2014;113(2):321–7. DOI: 10.1016/j.amjcard.2013.08.047

69. Van Tassell BW, Trankle CR, Canada JM, Carbone S, Buckley L, Kadariya D et al. IL-1 Blockade in Patients With Heart Failure with Preserved Ejection Fraction: Results From DHART2. Circulation: Heart Failure. 2018;11(8):e005036. DOI: 10.1161/CIRCHEARTFAILURE.118.005036

70. Haudek SB, Cheng J, Du J, Wang Y, Hermosillo-Rodriguez J, Trial J et al. Monocytic fbroblast precursors mediate fbrosis in angiotensin-II-induced cardiac hypertrophy. Journal of Molecular and Cellular Cardiology. 2010;49(3):499–507. DOI: 10.1016/j.yjmcc.2010.05.005

71. Kuwahara F, Kai H, Tokuda K, Takeya M, Takeshita A, Egashira K et al. Hypertensive Myocardial Fibrosis and Diastolic Dysfunction: Another Model of Inflammation? Hypertension. 2004;43(4):739–45. DOI: 10.1161/01.HYP.0000118584.33350.7d

72. Ramasubbu K, Estep J, White DL, Deswal A, Mann DL. Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. Journal of the American College of Cardiology. 2008;51(4):415–26. DOI: 10.1016/j.jacc.2007.10.009

73. Fukuta H, Sane DC, Brucks S, Litle WC. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation. 2005;112(3):357–63. DOI: 10.1161/CIRCULATIONAHA.104.519876

74. Nochioka K, Sakata Y, Miyata S, Miura M, Takada T, Tadaki S et al. Prognostic impact of statin use in patients with heart failure and preserved ejection fraction. Circulation Journal: Ofcial Journal of the Japanese Circulation Society. 2015;79(3):574–82. DOI: 10.1253/circj.CJ-14-0865

75. Alehagen U, Benson L, Edner M, Dahlström U, Lund LH. Association between use of statins and mortality in patients with heart failure and ejection fraction of ≥50. Circulation. Heart Failure. 2015;8(5):862–70. DOI: 10.1161/CIRCHEARTFAILURE.115.002143

76. Ovchinnikov A.G., Ojerelyeva M.V., Ageev F.T. Hypertensive lef ventricular hypertrophy is a risk factor for the development of a HFPEF but not a depressed lef ventricular ejection fraction within eight years. European Journal of Heart Failure. 2017;19(S1):328


Для цитирования:


Овчинников А.Г., Потехина А.В., Ибрагимова Н.М., Барабанова Е.А., Ющук Е.Н., Агеев Ф.Т. Механизмы плохой переносимости физической нагрузки у больных сердечной недостаточностью с сохраненной фракцией выброса. Часть I: Роль нарушений со стороны левых камер сердца. Кардиология. 2019;59(6S):4-16. https://doi.org/10.18087/cardio.n394

For citation:


Ovchinnikov A.G., Potekhina A.V., Ibragimova N.M., Barabanova E.A., Yushchyuk E.N., Ageev F.T. Mechanisms of exercise intolerance in patients with heart failure and preserved ejection fraction. Part I: The role of impairments in the left heart chambers. Kardiologiia. 2019;59(6S):4-16. (In Russ.) https://doi.org/10.18087/cardio.n394

Просмотров: 444


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 0022-9040 (Print)
ISSN 2412-5660 (Online)